Journal
MUCOSAL IMMUNOLOGY
Volume 7, Issue 2, Pages 428-439Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/mi.2013.62
Keywords
-
Categories
Funding
- Cancer Research Wales
- Wellcome Trust
- Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish
Ask authors/readers for more resources
Although elevated CD4(+)Foxp3(+) regulatory Tcell (Treg) frequencies within tumors are well documented, the functional and phenotypic characteristics of CD4(+)Foxp3(+)and CD4(+)Foxp3(-) Tcell subsets from matched blood, healthy colon, and colorectal cancer require in-depth investigation. Flow cytometry revealed that the majority of intratumoral CD4(+)Foxp3(+) T cells (Tregs) were Helios(+) and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood. Moreover, similar to 30% of intratumoral CD4(+)Foxp3(-) T cells expressed markers associated with regulatory functions, including latency-associated peptide (LAP), lymphocyte activation gene-3 (LAG-3), and CD25. This unique population of cells produced interleukin-10 (IL-10) and transforming growth factor-beta (TGF-beta), and was similar to 50-fold more suppressive than Foxp3(+) Tregs. Thus, intratumoral Tregs are diverse, posing multiple obstacles to immunotherapeutic intervention in colorectal malignancies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available